Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Costs, Effects and Cost Effectiveness of Sorafenib as Compared with BSC.
| Finding | Sorafenib | BSC |
|---|---|---|
| Lifetime cost per patient | 2,93,978 | 1,99,796 |
| Health consequences per patient | ||
| LYs | 0.68 | 0.43 |
| QALYs | 0.50 | 0.31 |
| Incremental cost | 94,182 | |
| Incremental benefit | ||
| LY | 0.25 | |
| QALY | 0.19 | |
| Incremental Cost-effectiveness Ratio | ||
| INR per person LY gained | 3,82,796 | |
| INR per person QALY gained | 5,07,520 | |
BSC: best supporting care, QALY: quality adjusted life years, LY: life years, INR: Indian national rupee.
